BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8940717)

  • 21. [Biodistribution of (99m)Tc-labeled anti-VEGF mAb 5-FU loaded polylactic acid nanoparticles in human gastric carcinoma xenografts].
    Huang KH; Liu JH; Zhu ZH; Li XX; Lu XP; Zhou SY
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1137-40. PubMed ID: 17715009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma.
    Li GP; Zhang H; Zhu CM; Zhang J; Jiang XF
    World J Gastroenterol; 2005 Oct; 11(40):6288-94. PubMed ID: 16419157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A human/mouse chimeric monoclonal antibody against intercellular adhesion molecule-1 for tumor radioimmunoimaging.
    Yamamura M; Hinoda Y; Sasaki S; Tsujisaki M; Oriuchi N; Endo K; Imai K
    Jpn J Cancer Res; 1996 Apr; 87(4):405-11. PubMed ID: 8641973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in biodistribution of the anti-(carcinoembryonic antigen) murine monoclonal antibody CE-25, its F(ab')2 fragment and its intact mainly human chimeric form CE 4-8-13. Dependence on tumour size and amount of antibody injected.
    Westera G; Rülicke T; Smith A; Duewell S
    Cancer Immunol Immunother; 1994 Dec; 39(6):375-82. PubMed ID: 8001025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor targeting with radiolabeled antibodies in a human carcinoembryonic antigen transgenic mouse model.
    Szalai G; Williams LE; Primus FJ
    Int J Cancer; 2000 Mar; 85(6):751-6. PubMed ID: 10709090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of interleukin-2 on the biodistribution of technetium-99m-labelled anti-CEA monoclonal antibody in mice bearing human tumour xenografts.
    Nakamura K; Kubo A
    Eur J Nucl Med; 1994 Sep; 21(9):924-9. PubMed ID: 7995285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
    Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY
    Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
    Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
    J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
    Kim JC; Roh SA; Koo KH; Ryu JH; Hong HK; Oh SJ; Ryu JS; Kim HJ; Bodmer WF
    Int J Cancer; 2002 Feb; 97(4):542-7. PubMed ID: 11802220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations in radioimmunoscintigraphic detection of tumor showed by five monoclonal antibodies to carcinoembryonic antigen.
    Kohno K; Nakata K; Kusumoto Y; Ishii N; Kohji T; Matsuoka Y; Nishi S; Nagataki S
    Ann Nucl Med; 1991 Jul; 5(2):69-75. PubMed ID: 1777353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
    Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
    J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential usefulness of 99mTc-labeled monoclonal antibody A7 for immunoscintigraphy of human pancreatic carcinoma.
    Matsumura H; Otsuji E; Kobayashi S; Okamoto K; Toma A; Yamagishi H
    Anticancer Res; 2001; 21(5):3433-7. PubMed ID: 11848505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
    Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.
    Takasu S; Takahashi T; Okamoto S; Oriuchi N; Nakayashiki N; Okamoto K; Muramatsu H; Hayashi T; Nakahara N; Mizuno M; Wakabayashi T; Higuchi T; Endo K; Kozaki K; Miyaishi O; Saga S; Ueda R; Yoshida J; Yoshikawa K
    J Neurooncol; 2003 Jul; 63(3):247-56. PubMed ID: 12892230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging of HER2/neu expression in BT-474 human breast cancer xenografts in athymic mice using [(99m)Tc]-HYNIC-trastuzumab (Herceptin) Fab fragments.
    Tang Y; Scollard D; Chen P; Wang J; Holloway C; Reilly RM
    Nucl Med Commun; 2005 May; 26(5):427-32. PubMed ID: 15838425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental study of the relationship between in vitro binding activity and in vivo tumor accumulation of radiolabeled anti-CEA monoclonal antibodies].
    Takeda A; Miyoshi T; Arimizu N; Isono K
    Nihon Shokakibyo Gakkai Zasshi; 1991 Jun; 88(6):1288-96. PubMed ID: 1890753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioimmunoscintigraphy of pancreatic cancer in tumor-bearing athymic nude mice using (99m)technetium-labeled anti-KL-6/MUC1 antibody.
    Matsumura K; Niki I; Tian H; Takuma M; Hongo N; Matsumoto S; Mori H
    Radiat Med; 2008 Apr; 26(3):133-9. PubMed ID: 18683568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the 111In-(Sn)-citrate method to label antibodies for radioimmunotargeting studies.
    Nakamura K; Ruiz-Juvera A; Kubo A; Hashimoto S
    Int J Rad Appl Instrum B; 1992 Jan; 19(1):21-5. PubMed ID: 1577610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoembryonic antigen and alpha-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model.
    Wang ZF; Stein R; Sharkey RM; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):869s-872s. PubMed ID: 1688735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diverse characteristics of 111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts.
    Pimm MV; Perkins AC; Baldwin RW
    Eur J Nucl Med; 1987; 12(10):515-21. PubMed ID: 3569340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.